Cite
AB0697 ANTI-SARS-COV-2 ANTIBODIES AND AUTOANTIBODIES IN COVID-19 PATIENTS SURVIVED AFTER ICU ADMISSION, 6 MONTHS LATER
MLA
Anastasia Kotanidou, et al. “Ab0697 Anti-Sars-Cov-2 Antibodies and Autoantibodies in Covid-19 Patients Survived After Icu Admission, 6 Months Later.” Annals of the Rheumatic Diseases, vol. 80, May 2021, p. 1381.2-1381. EBSCOhost, https://doi.org/10.1136/annrheumdis-2021-eular.3554.
APA
Anastasia Kotanidou, P.G. Vlachoyiannopoulos, Marinos C. Dalakas, L. Chatzis, H. Alexopoulos, Edison Jahaj, A. G. Tzioufas, Eleni Magira, & K. Bitzogli. (2021). Ab0697 Anti-Sars-Cov-2 Antibodies and Autoantibodies in Covid-19 Patients Survived After Icu Admission, 6 Months Later. Annals of the Rheumatic Diseases, 80, 1381.2-1381. https://doi.org/10.1136/annrheumdis-2021-eular.3554
Chicago
Anastasia Kotanidou, P.G. Vlachoyiannopoulos, Marinos C. Dalakas, L. Chatzis, H. Alexopoulos, Edison Jahaj, A. G. Tzioufas, Eleni Magira, and K. Bitzogli. 2021. “Ab0697 Anti-Sars-Cov-2 Antibodies and Autoantibodies in Covid-19 Patients Survived After Icu Admission, 6 Months Later.” Annals of the Rheumatic Diseases 80 (May): 1381.2-1381. doi:10.1136/annrheumdis-2021-eular.3554.